Literature DB >> 11408249

Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VII. Enteropathogenic Escherichia coli: physiological alterations from an extracellular position.

G Hecht1.   

Abstract

Enteropathogenic Escherichia coli (EPEC) is primarily associated with infantile diarrhea in developing countries. This intriguing pathogen exerts numerous physiological effects on its host target tissue, the intestinal epithelium, all from an extracellular location. Expression of a type III secretory apparatus allows this organism to transfer bacterial effector molecules directly into host cells. As a result of EPEC attachment to and/or translocation of proteins into intestinal epithelial cells, many signaling cascades are activated. Ultimately, host functions are perturbed, including alteration of ion transport, disruption of the tight junction barrier, and activation of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408249     DOI: 10.1152/ajpgi.2001.281.1.G1

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  31 in total

1.  Differential infection of polarized epithelial cell lines by sialic acid-dependent and sialic acid-independent rotavirus strains.

Authors:  M Ciarlet; S E Crawford; M K Estes
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 2.  Virulence of enteropathogenic Escherichia coli, a global pathogen.

Authors:  S C Clarke; R D Haigh; P P E Freestone; P H Williams
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

3.  Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1.

Authors:  Takeshi Matsuzawa; Asaomi Kuwae; Sei Yoshida; Chihiro Sasakawa; Akio Abe
Journal:  EMBO J       Date:  2004-08-19       Impact factor: 11.598

Review 4.  Probiotics, enteric and diarrheal diseases, and global health.

Authors:  Geoffrey A Preidis; Colin Hill; Richard L Guerrant; B S Ramakrishna; Gerald W Tannock; James Versalovic
Journal:  Gastroenterology       Date:  2010-11-12       Impact factor: 22.682

5.  Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice.

Authors:  Chien-Chang Chen; Steve Louie; Beth McCormick; W Allan Walker; Hai Ning Shi
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

6.  Toll-like receptor 4 contributes to colitis development but not to host defense during Citrobacter rodentium infection in mice.

Authors:  Mohammed A Khan; Caixia Ma; Leigh A Knodler; Yanet Valdez; Carrie M Rosenberger; Wanyin Deng; B Brett Finlay; Bruce A Vallance
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  Mechanism underlying inhibition of intestinal apical Cl/OH exchange following infection with enteropathogenic E. coli.

Authors:  Ravinder K Gill; Alip Borthakur; Kim Hodges; Jerrold R Turner; Daniel R Clayburgh; Seema Saksena; Ayesha Zaheer; Krishnamurthy Ramaswamy; Gail Hecht; Pradeep K Dudeja
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

Review 8.  Enteric infections, diarrhea, and their impact on function and development.

Authors:  William A Petri; Mark Miller; Henry J Binder; Myron M Levine; Rebecca Dillingham; Richard L Guerrant
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 9.  Bacteria in the intestine, helpful residents or enemies from within?

Authors:  Geraldine O Canny; Beth A McCormick
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

10.  Citrobacter rodentium Infection Inhibits Colonic P-glycoprotein Expression.

Authors:  Mitul Patel; Anoop Kumar; Dulari Jayawardena; Shubha Priyamvada; Arivarasu N Anbazhagan; Waddah A Alrefai; Ravinder K Gill; Pradeep K Dudeja; Seema Saksena
Journal:  Gene Rep       Date:  2019-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.